Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection
- PMID: 18755983
- PMCID: PMC2581993
- DOI: 10.1182/blood-2008-05-155960
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection
Abstract
Human T-lymphotropic viruses types I and II (HTLV-I and HTLV-II) cause chronic infections of T lymphocytes that may lead to leukemia and myelopathy. However, their long-term effects on blood counts and hematopoiesis are poorly understood. We followed 151 HTLV-I-seropositive, 387 HTLV-II-seropositive, and 799 HTLV-seronegative former blood donors from 5 U.S. blood centers for a median of 14.0 years. Complete blood counts were performed every 2 years. Multivariable repeated measures analyses were conducted to evaluate the independent effect of HTLV infection and potential confounders on 9 hematologic measurements. Participants with HTLV-II had significant (P < .05) increases in their adjusted lymphocyte counts (+126 cells/mm(3); approximately +7%), hemoglobin (+2 g/L [+0.2 g/dL]) and mean corpuscular volume (MCV; 1.0 fL) compared with seronegative participants. Participants with HTLV-I and HTLV-II had higher adjusted platelet counts (+16 544 and +21 657 cells/mm(3); P < .05) than seronegatives. Among all participants, time led to decreases in platelet count and lymphocyte counts, and to increases in MCV and monocytes. Sex, race, smoking, and alcohol consumption all had significant effects on blood counts. The HTLV-II effect on lymphocytes is novel and may be related to viral transactivation or immune response. HTLV-I and HTLV-II associations with higher platelet counts suggest viral effects on hematopoietic growth factors or cytokines.
Figures


Comment in
-
Hematologic hints of HTLV-2 in US blood donors.Blood. 2008 Nov 15;112(10):3919-20. doi: 10.1182/blood-2008-09-179085. Blood. 2008. PMID: 18988871 No abstract available.
Similar articles
-
Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2: a prospective analysis.Arch Pathol Lab Med. 2000 Apr;124(4):550-5. doi: 10.5858/2000-124-0550-LAIFBD. Arch Pathol Lab Med. 2000. PMID: 10747312
-
Hematologic hints of HTLV-2 in US blood donors.Blood. 2008 Nov 15;112(10):3919-20. doi: 10.1182/blood-2008-09-179085. Blood. 2008. PMID: 18988871 No abstract available.
-
Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study Investigators.J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):332-8. doi: 10.1097/00042560-199804010-00007. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9525434
-
Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.Transfus Clin Biol. 2016 Feb;23(1):13-9. doi: 10.1016/j.tracli.2015.12.001. Epub 2016 Jan 5. Transfus Clin Biol. 2016. PMID: 26778839 Free PMC article. Review.
-
Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S69-75. doi: 10.1097/00042560-199600001-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8797707 Review.
Cited by
-
Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.Leuk Res Treatment. 2012;2012:876153. doi: 10.1155/2012/876153. Epub 2011 Dec 29. Leuk Res Treatment. 2012. PMID: 23213551 Free PMC article.
-
Genetic diversity of STLV-2 and interspecies transmission of STLV-3 in wild-living bonobos.Virus Evol. 2016 May 25;2(1):vew011. doi: 10.1093/ve/vew011. eCollection 2016 Jan. Virus Evol. 2016. PMID: 27774304 Free PMC article.
-
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses.Retrovirology. 2012 Mar 29;9:26. doi: 10.1186/1742-4690-9-26. Retrovirology. 2012. PMID: 22458338 Free PMC article.
-
Fine tuning of the temporal expression of HTLV-1 and HTLV-2.Front Microbiol. 2013 Sep 2;4:235. doi: 10.3389/fmicb.2013.00235. Front Microbiol. 2013. PMID: 24032027 Free PMC article. Review.
-
Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization.J Virol. 2011 Dec;85(23):12673-85. doi: 10.1128/JVI.05296-11. Epub 2011 Sep 14. J Virol. 2011. PMID: 21917984 Free PMC article.
References
-
- Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982;218:571–573. - PubMed
-
- Poiesz BJ, Ruscetti F, Reitz M, Kalyanaraman V, Gallo R. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature. 1981;294:268–271. - PubMed
-
- Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1992;117:933–946. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources